期刊文献+

卡维地洛治疗老年舒张性心力衰竭患者疗效观察 被引量:2

Therapeutic effect of Carvedilol on diastolic heart failure of elder patients
暂未订购
导出
摘要 目的探讨卡维地洛对老年舒张性心力衰竭(DHF)患者临床疗效。方法选择2010年2月~2011年10月收治住院的将老年舒张性心力衰竭的患者84例,随机分为观察组和对照组,每组各42例。对照组予常规抗舒张性心力衰竭治疗,观察组在对照组治疗基础上加用卡维地洛,疗程3个月。比较两组治疗前后6min步行试验,应用超声心动图(UCG)测定两组治疗前后心脏舒张功能指标,并进行统计学分析。结果治疗后观察组总有效率明显高于对照组,差异有统计学意义(P<0.05)。观察组治疗后E峰、A峰、E/A比值和6min步行试验均显著改善(P<0.05),与对照组比较,差异有统计学意义(P<0.05)。结论应用卡维地洛可改善老年舒张性心力衰竭患者的左室功能。 Objective To investigate the effects of Carvedilol on diastolic heart failure in eider patients. Methods Eighty four cases of elder patients with diastolic heart failure in our hospital were randomly divided into observation group and control group, with 42 cases in each group. The control group was given routine treatment of diastolic heart failure and the observation group was treated with Carvediol based on the control group. The course of treatment was 3 months. The 6-min walk test was performed and compared between the two groups. The parameters of the diastolic function of heart before and after treatment in two groups were determined by ultrasonic cardiogram. Results After treatment, the total effective rate in treatment group was higher than that in control group (P 〈 0.05). E peak, A peak, E/A value and 6 rain walk test in the observation group was significantly better than those in the control group (P 〈 0.05). Conclusion Carvedilol can improve the function of left ventricle of elder paiients with diastolic heart failure.
出处 《中国当代医药》 2012年第18期90-91,共2页 China Modern Medicine
关键词 卡维地洛 老年舒张性心力衰竭 6 MIN步行试验 心脏舒张功能 Carvedilol Elder Diastolic heart failure 6 min walk test Diastolic function
  • 相关文献

参考文献8

二级参考文献98

  • 1赵玉兰,王婷,程劲松,杨树涵.阿托伐他汀对大鼠肥厚心肌组织HIF-1α、VEGF表达的影响[J].郑州大学学报(医学版),2009,44(2):402-405. 被引量:2
  • 2王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 3Benjamin E J, Levy D. Why is left Ventricular hypertrophy so predictive of morbidity and mortality [ J ]. Am J Med Sci,1999,317(3) :168.
  • 4Udelson JE. Ventricular remodeling in heart failure and the effect of 15-blochade [ J ]. J Am Cardiol,2004,93 (9A) :43B.
  • 5Feuerstein GZ, Bril A, Ruffolo RR Jr. Protective effects of carvedilol in the myocardium [ J ]. Am J Cardiol, 1997,80 (11A) :41L.
  • 6Kenchaiah S, Pfeffer MA. Cardiac remodeling in systemic hypertension [ J ]. Med Clin North Am, 2004,88 ( 1 ) : 115.
  • 7Weber KT, Brilla CG,Janicki JS. Myocardial fibrosis:functional significance and regulatory factors [ J ]. Cardiovasc Res,1993,27(3) :341.
  • 8Berk BC, Fujiwara K,Lehoux S. ECM remodeling in hypertensive heart disease [ J ]. J Clin Invest,2007,117 ( 3 ) : 568.
  • 9Iwanaga Y, Aoyama T, Kihara Y, et al. Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats [ J ]. J Am Coll Cardiol, 2002,39 (8) :1 384.
  • 10Mujumdar VS, Smiley LM, Tyagi SC. Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength[J]. Int J Cardiol,2001,79(2/3) :277.

共引文献3792

同被引文献39

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部